These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33557756)

  • 1. Correlation of the severity of coronary artery disease with patients' metabolic profile- rationale, design and baseline patient characteristics of the CorLipid trial.
    Karagiannidis E; Sofidis G; Papazoglou AS; Deda O; Panteris E; Moysidis DV; Stalikas N; Kartas A; Papadopoulos A; Stefanopoulos L; Karvounis H; Gika H; Theodoridis G; Sianos G
    BMC Cardiovasc Disord; 2021 Feb; 21(1):79. PubMed ID: 33557756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GEnetic Syntax Score: a genetic risk assessment implementation tool grading the complexity of coronary artery disease-rationale and design of the GESS study.
    Vizirianakis IS; Chatzopoulou F; Papazoglou AS; Karagiannidis E; Sofidis G; Stalikas N; Stefopoulos C; Kyritsis KA; Mittas N; Theodoroula NF; Lampri A; Mezarli E; Kartas A; Chatzidimitriou D; Papa-Konidari A; Angelis E; Karvounis Η; Sianos G
    BMC Cardiovasc Disord; 2021 Jun; 21(1):284. PubMed ID: 34103005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine Learning Algorithm to Predict Obstructive Coronary Artery Disease: Insights from the CorLipid Trial.
    Panteris E; Deda O; Papazoglou AS; Karagiannidis E; Liapikos T; Begou O; Meikopoulos T; Mouskeftara T; Sofidis G; Sianos G; Theodoridis G; Gika H
    Metabolites; 2022 Aug; 12(9):. PubMed ID: 36144220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of Serum Acylcarnitines with Clinical Presentation and Severity of Coronary Artery Disease.
    Deda O; Panteris E; Meikopoulos T; Begou O; Mouskeftara T; Karagiannidis E; Papazoglou AS; Sianos G; Theodoridis G; Gika H
    Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease.
    Karagiannidis E; Moysidis DV; Papazoglou AS; Panteris E; Deda O; Stalikas N; Sofidis G; Kartas A; Bekiaridou A; Giannakoulas G; Gika H; Theodoridis G; Sianos G
    Cardiovasc Diabetol; 2022 May; 21(1):70. PubMed ID: 35525960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of clinical, laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors - rationale and design of the "Beyond-SMuRFs Study".
    Moysidis DV; Daios S; Anastasiou V; Liatsos AC; Papazoglou AS; Karagiannidis E; Kamperidis V; Makedou K; Thisiadou A; Karalazou P; Papadakis M; Savopoulos C; Ziakas A; Giannakoulas G; Vassilikos V; Giannopoulos G
    BMC Cardiovasc Disord; 2023 Mar; 23(1):149. PubMed ID: 36959584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography.
    Arbel Y; Finkelstein A; Halkin A; Birati EY; Revivo M; Zuzut M; Shevach A; Berliner S; Herz I; Keren G; Banai S
    Atherosclerosis; 2012 Dec; 225(2):456-60. PubMed ID: 23040448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of stable coronary artery disease and its biomarkers differ between men and women undergoing angiography.
    Gijsberts CM; Gohar A; Ellenbroek GH; Hoefer IE; de Kleijn DP; Asselbergs FW; Nathoe HM; Agostoni P; Rittersma SZ; Pasterkamp G; Appelman Y; den Ruijter HM
    Atherosclerosis; 2015 Jul; 241(1):234-40. PubMed ID: 25670231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
    Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW
    Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Molecule Counting of High-Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study.
    McCarthy CP; Ibrahim NE; Lyass A; Li Y; Gaggin HK; Simon ML; Mukai R; Gandhi P; Kelly N; Motiwala SR; van Kimmenade RRJ; Massaro JM; D'Agostino RB; Januzzi JL
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29519811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort study.
    Kott KA; Vernon ST; Hansen T; Yu C; Bubb KJ; Coffey S; Sullivan D; Yang J; O'Sullivan J; Chow C; Patel S; Chong J; Celermajer DS; Kritharides L; Grieve SM; Figtree GA
    BMJ Open; 2019 Sep; 9(9):e028649. PubMed ID: 31537558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untargeted high-resolution plasma metabolomic profiling predicts outcomes in patients with coronary artery disease.
    Mehta A; Liu C; Nayak A; Tahhan AS; Ko YA; Dhindsa DS; Kim JH; Hayek SS; Sperling LS; Mehta PK; Sun YV; Uppal K; Jones DP; Quyyumi AA
    PLoS One; 2020; 15(8):e0237579. PubMed ID: 32810196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of Plasma Adiponectin and Waist-hip Ratio with Coronary Artery Disease.
    Rashiti P; Elezi S; Behluli I; Mucaj S
    Med Arch; 2016 Dec; 70(6):413-418. PubMed ID: 28210011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography.
    Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A; Hornemann T
    Atherosclerosis; 2015 May; 240(1):216-21. PubMed ID: 25801014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision phenotyping, panomics, and system-level bioinformatics to delineate complex biologies of atherosclerosis: rationale and design of the "Genetic Loci and the Burden of Atherosclerotic Lesions" study.
    Voros S; Maurovich-Horvat P; Marvasty IB; Bansal AT; Barnes MR; Vazquez G; Murray SS; Voros V; Merkely B; Brown BO; Warnick GR
    J Cardiovasc Comput Tomogr; 2014; 8(6):442-51. PubMed ID: 25439791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes.
    Samman Tahhan A; Sandesara P; Hayek SS; Hammadah M; Alkhoder A; Kelli HM; Topel M; O'Neal WT; Ghasemzadeh N; Ko YA; Gafeer MM; Abdelhadi N; Choudhary F; Patel K; Beshiri A; Murtagh G; Kim J; Wilson P; Shaw L; Vaccarino V; Epstein SE; Sperling L; Quyyumi AA
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29467150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Ceramides.
    Meeusen JW; Donato LJ; Bryant SC; Baudhuin LM; Berger PB; Jaffe AS
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1933-1939. PubMed ID: 29903731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography.
    LaFramboise WA; Dhir R; Kelly LA; Petrosko P; Krill-Burger JM; Sciulli CM; Lyons-Weiler MA; Chandran UR; Lomakin A; Masterson RV; Marroquin OC; Mulukutla SR; McNamara DM
    BMC Med; 2012 Dec; 10():157. PubMed ID: 23216991
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.